effet secondaire semaglutide Ozempic, Wegovy... des effets secondaires possibles avec la prise de médicaments contre l'obésité 💊 Ozempic : faut-il s'inquiéter

Currently, in 2026, it remains in phase 3 clinical trials

Industry response Novo Nordisk, which makes Ozempic and Wegovy, welcomed the potential policy change, saying in a statement, We believe that comprehensive coverage through government and commercial insurance plans is critical to affordable health care and treatment options. Eli Lilly, the maker of Mounjaro and Zepbound, has not commented publicly

Does PCOS increase my risk of developing diabetes

Boston Medical Group Can Make You a Personalized Weight Loss Treatment Plan What you eat while taking GLP-1 medications significantly impacts their effectiveness as an anti-obesity medication

Help your clients navigate the growing use of GLP-1 and GIP medications with confidence and professionalism